EVOKE PHARMA, INC. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-02-24: Reporting owner PYSZCZYMUKA GREG; Form 3; Security No securities are beneficially owned.; Transaction Holding.
- 2024-10-22: Reporting owner Smeal Benjamin C.; Form 3; Security No securities are beneficially owned.; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-24 holding as of filing | PYSZCZYMUKA GREG Director | 3 | No securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2025-02-24 | |
| 2024-10-22 holding as of filing | Smeal Benjamin C. Director | 3 | No securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2024-10-22 |